Payer reap rewards of new drug spending over the long haul
Washington, D.C. - Health plans and payers will save money inthe long run if they spend more on newer medicines that can keep patientshealthy and lower healthcare expenditures overall. That's the conclusionof several economists at a recent briefing hosted by the American EnterpriseInstitute and the National Pharmaceutical Council.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
